Cryo-Cell International (NYSEAMERICAN:CCEL) Posts Quarterly Earnings Results

Cryo-Cell International (NYSEAMERICAN:CCEL) announced its quarterly earnings data on Monday. The company reported $0.07 EPS for the quarter, reports. Cryo-Cell International had a negative net margin of 31.02% and a negative return on equity of 64.31%. The business had revenue of $7.85 million during the quarter.

Cryo-Cell International Price Performance

CCEL stock traded up $0.80 during trading on Thursday, reaching $7.55. 21,543 shares of the company were exchanged, compared to its average volume of 9,709. The company has a market capitalization of $61.16 million, a P/E ratio of -5.85 and a beta of 0.45. The business’s 50-day moving average is $5.69. Cryo-Cell International has a twelve month low of $3.62 and a twelve month high of $8.15.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Northern Trust Corp bought a new position in Cryo-Cell International in the 4th quarter valued at approximately $151,000. Cerity Partners LLC bought a new position in shares of Cryo-Cell International during the fourth quarter valued at $83,000. Rowlandmiller & PARTNERS.ADV acquired a new position in shares of Cryo-Cell International during the first quarter worth $108,000. Finally, Vanguard Group Inc. lifted its holdings in shares of Cryo-Cell International by 13.7% during the third quarter. Vanguard Group Inc. now owns 83,883 shares of the company’s stock worth $441,000 after purchasing an additional 10,095 shares during the period. 10.44% of the stock is currently owned by institutional investors.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.